Received Apr 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
she might have COVID too; she might have COVID too; This is a spontaneous report received from a Consumer or other non HCP, Program ID:. A female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Primary Immunization series complete), for covid-19 immunisation. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "she might have COVID too". The clinical course was reported as follows: the patient's husband had COVID, and the reporter stated she might have COVID too. They got all those COVID-19 shots; they were all Pfizer. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.